Language: English
Published by New York Academy of Sciences, New York, 1986
ISBN 10: 0897663322 ISBN 13: 9780897663328
Seller: John M. Gram, Port Huron, MI, U.S.A.
First Edition
Soft cover. Condition: Very Good. 1st Edition. mild shop wear, otherwise clean and sound, new remainder, no creasing, octavo paperback, 408 pages.
Language: English
Published by New York Academy of Sciences, 1986
ISBN 10: 0897663314 ISBN 13: 9780897663311
Seller: Book Bungalow, Edinburgh, United Kingdom
Hardcover. Condition: Very Good. Tight clean hardback, name on fly, not a library book.
Language: English
Published by New York Academy of Sciences, USA, 1986
ISBN 10: 0897663314 ISBN 13: 9780897663311
Seller: The Book Exchange, Macclesfield, CHESH, United Kingdom
Hardcover. Condition: Good. No Jacket. 0897663314. Blue cloth hardcover, from closed pharmaceutical company library. 408 pages, index, illustrated with charts, tables and diagrams. Contents paper clip marks on front endpapers clean, tight and bright. Book.
Language: German
Published by Berlin, Heidelberg, New York : Springer, 1975
ISBN 10: 3540070354 ISBN 13: 9783540070351
Seller: books4less (Versandantiquariat Petra Gros GmbH & Co. KG), Welling, Germany
Broschiert. Condition: Gut. XV, 182 S. Das hier angebotene Buch stammt aus einer teilaufgelösten wissenschaftlichen Bibliothek und trägt die entsprechenden Kennzeichnungen (Rückenschild, Instituts-Stempel.). Schnitt und Einband sind etwas staubschmutzig; der Buchzustand ist ansonsten ordentlich und dem Alter entsprechend gut. Sprache: Deutsch Gewicht in Gramm: 400.
Language: English
Published by New York Academy of Sciences, NY, 1986
ISBN 10: 0897663322 ISBN 13: 9780897663328
Seller: Tiber Books, Cockeysville, MD, U.S.A.
Paperback. Condition: Very Good. . . . . 8vo, paperback. Vg condition. Exterior faintly rubbed, contents bright & clean, binding tight. 408 p. Papers presented at a conference held by the Engineering Foundation and the Society for Analytical Cytology on December 7-12, 1983, at the Cloister, Sea Island, Georgia.
Language: English
Published by Berlin/ Heidelberg/ New York/ Tokyo, Springer, 1985
ISBN 10: 0387153764 ISBN 13: 9780387153766
Seller: Antiquariat Hans-Jürgen Ketz, Münster, NRW, Germany
VIII, 141 Seiten. 49 graphische Darstellungen und 56 Tabellen. Großoktav (24x16 cm) Orig.Karton. ** Gutes, sauberes Exemplar. Mit persönlicher Widmung des Autors J. Schumann.
Seller: BGV Books LLC, Murray, KY, U.S.A.
Condition: Good. Exact ISBN match. Immediate shipping. No funny business.
Language: English
Published by Springer-Verlag Publishing, 2014
ISBN 10: 1493913921 ISBN 13: 9781493913923
Seller: Salish Sea Books, Bellingham, WA, U.S.A.
Condition: Very Good. Very Good++; Hardcover; Close to new condition; Covers are still glossy with "straight" edge-corners; Unblemished textblock edges; The endpapers and all text pages are bright and unmarked; Binding is tight with a straight spine; This book will be stored and delivered in a sturdy cardboard box with foam padding; Medium Format (8.5" - 9.75" tall); Blue, purple, and orange covers with title in white lettering; 2014, Springer-Verlag Publishing; 826 pages; "Targeted Therapy of Acute Myeloid Leukemia (Current Cancer Research)," by Michael Andreeff.
Seller: Ria Christie Collections, Uxbridge, United Kingdom
£ 136.79
Quantity: Over 20 available
Add to basketCondition: New. In.
Language: English
Published by Springer-Verlag New York Inc., New York, 2014
ISBN 10: 1493913921 ISBN 13: 9781493913923
Seller: Grand Eagle Retail, Bensenville, IL, U.S.A.
Hardcover. Condition: new. Hardcover. This book provides an unprecedented overview of "Targeted Therapies" for acute myeloid leukemias. It aims at an almost comprehensive coverage of the diverse therapeutic strategies that have been developed during the last decade and are now being evaluated in early clinical trials. Paired and authoritative chapters by leading research scientists and clinicians explain basic concepts and clinical translation of topics that include the underlying genetic and proteomic abnormalities of AML, the development of novel nucleoside analogues, the roles of microRNAs, apoptosis regulators Bcl-2 and p53 and of critical cell signaling proteins such as PIM, FLT3, Raf/MEK, PI3K/AKT/mTOR and aurora kinases. Chapters on epigenetic mechanisms, nuclear receptors, cell surface antigens, the hypoxic leukemia microenvironment, stem cells and leukemia metabolism provide insights into leukemia cell vulnerabilities. Cell therapies utilizing T-, NK- and mesenchymal stem cells and progress in hematopoietic transplantation strategies round up this overview of the multi-dimensional therapeutic landscape in which leukemia specialists develop treatment strategies that are expected to make "leukemia history" in the near future. Chapters on epigenetic mechanisms, nuclear receptors, cell surface antigens, the hypoxic leukemia microenvironment, stem cells and leukemia metabolism provide insights into leukemia cell vulnerabilities. Shipping may be from multiple locations in the US or from the UK, depending on stock availability.
Seller: moluna, Greven, Germany
Condition: New.
Seller: moluna, Greven, Germany
Gebunden. Condition: New.
Seller: preigu, Osnabrück, Germany
Taschenbuch. Condition: Neu. Targeted Therapy of Acute Myeloid Leukemia | Michael Andreeff | Taschenbuch | xix | Englisch | 2016 | Springer US | EAN 9781493939893 | Verantwortliche Person für die EU: Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu.
Condition: New.
Condition: New.
Seller: Books Puddle, New York, NY, U.S.A.
Condition: New. 1st edition NO-PA03JAN2015-KAP.
Condition: As New. Unread book in perfect condition.
Language: English
Published by Springer New York, Springer US, 2014
ISBN 10: 1493913921 ISBN 13: 9781493913923
Seller: AHA-BUCH GmbH, Einbeck, Germany
Buch. Condition: Neu. Druck auf Anfrage Neuware - Printed after ordering - This book provides an unprecedented overview of 'Targeted Therapies' for acute myeloid leukemias. It aims at an almost comprehensive coverage of the diverse therapeutic strategies that have been developed during the last decade and are now being evaluated in early clinical trials. Paired and authoritative chapters by leading research scientists and clinicians explain basic concepts and clinical translation of topics that include the underlying genetic and proteomic abnormalities of AML, the development of novel nucleoside analogues, the roles of microRNAs, apoptosis regulators Bcl-2 and p53 and of critical cell signaling proteins such as PIM, FLT3, Raf/MEK, PI3K/AKT/mTOR and aurora kinases. Chapters on epigenetic mechanisms, nuclear receptors, cell surface antigens, the hypoxic leukemia microenvironment, stem cells and leukemia metabolism provide insights into leukemia cell vulnerabilities. Cell therapies utilizing T-, NK- and mesenchymal stem cells and progress in hematopoietic transplantation strategies round up this overview of the multi-dimensional therapeutic landscape in which leukemia specialists develop treatment strategies that are expected to make 'leukemia history' in the near future.
Seller: Little Moon Books, San Francisco, CA, U.S.A.
First Edition
Hardcover. Condition: Very Good. 1st Edition. Hardcover, 455 pages, 1999. First Edition . A Nearly Very Good copy. Book has moderate wear, crease or crimp to a few pages. Text appears clean.
Condition: As New. Unread book in perfect condition.
Language: English
Published by Springer New York, Springer US, 2016
ISBN 10: 1493939890 ISBN 13: 9781493939893
Seller: AHA-BUCH GmbH, Einbeck, Germany
Taschenbuch. Condition: Neu. Druck auf Anfrage Neuware - Printed after ordering - This book provides an unprecedented overview of 'Targeted Therapies' for acute myeloid leukemias. It aims at an almost comprehensive coverage of the diverse therapeutic strategies that have been developed during the last decade and are now being evaluated in early clinical trials. Paired and authoritative chapters by leading research scientists and clinicians explain basic concepts and clinical translation of topics that include the underlying genetic and proteomic abnormalities of AML, the development of novel nucleoside analogues, the roles of microRNAs, apoptosis regulators Bcl-2 and p53 and of critical cell signaling proteins such as PIM, FLT3, Raf/MEK, PI3K/AKT/mTOR and aurora kinases. Chapters on epigenetic mechanisms, nuclear receptors, cell surface antigens, the hypoxic leukemia microenvironment, stem cells and leukemia metabolism provide insights into leukemia cell vulnerabilities. Cell therapies utilizing T-, NK- and mesenchymal stem cells and progress in hematopoietic transplantation strategies round up this overview of the multi-dimensional therapeutic landscape in which leukemia specialists develop treatment strategies that are expected to make 'leukemia history' in the near future.
Seller: Books Puddle, New York, NY, U.S.A.
Condition: New. pp. 826.
Seller: Revaluation Books, Exeter, United Kingdom
Hardcover. Condition: Brand New. 1st edition. 826 pages. 9.25x6.25x2.00 inches. In Stock.
Seller: Kennys Bookshop and Art Galleries Ltd., Galway, GY, Ireland
Condition: New.
Language: English
Published by Springer, Berlin, Springer, 2016
ISBN 10: 3662500523 ISBN 13: 9783662500521
Seller: AHA-BUCH GmbH, Einbeck, Germany
Taschenbuch. Condition: Neu. Druck auf Anfrage Neuware - Printed after ordering - How Do We Treat Hematology and Oncology have seen rapid progress and advances during recent years. Increased knowledge of tumor biology, epidemiology, molecular genetics, growth reg- lation, and cellular functions has led to novel therapeutic paradigms. Targeted trea- ment approaches, antibodies, immunotherapy, and other new techniques complement classic chemotherapy, radiotherapy, and surgery. Patients are increasingly well educated as web-based information on diagnostic and therapeutic options as well as quality ma- agement and tumor outcome data are readily available. In this dynamic and fast-paced environment, it is of central importance to base clinical decisions and medical practice on the best available evidence. Continuous quality ma- agement, with clinical process documentation, standardization, and evaluation, leads to improved patient care and long-term outcomes. For these reasons, we have started to systematically capture and evaluate data on diagnosis, treatment, and outcomes of p- tients with solid tumors and hematological neoplasms at the Freiburg University Med- cal Center. We have developed standard operating procedures, clinical pathways, and diagnostic and therapeutic processes, following the principles of 'Good Clinical Pra- tice.' Tese processes (e.g., detailed protocols for chemotherapy application, treatment fowcharts, clinical pathways) are continuously tested and validated in clinical practice.
Seller: Mispah books, Redhill, SURRE, United Kingdom
Hardcover. Condition: Like New. Like New. book.
Language: English
Published by Wiley & Sons, Incorporated, John, 1999
ISBN 10: 0471013455 ISBN 13: 9780471013457
Seller: Better World Books, Mishawaka, IN, U.S.A.
Condition: Very Good. Former library copy. Pages intact with possible writing/highlighting. Binding strong with minor wear. Dust jackets/supplements may not be included. Includes library markings. Stock photo provided. Product includes identifying sticker. Better World Books: Buy Books. Do Good.
Condition: New.
Seller: Mispah books, Redhill, SURRE, United Kingdom
Hardcover. Condition: New. NEW. SHIPS FROM MULTIPLE LOCATIONS. book.
Language: German
Published by Berlin, Heidelberg, New York : Springer, 1975
ISBN 10: 3540070354 ISBN 13: 9783540070351
Seller: NEPO UG, Rüsselsheim am Main, Germany
Bibliothekseinband. Condition: Gut. XV, 182 S. : 97 Ill. u. graph. Darst., , 24 cm Beiträge teilw. dt., teilw. engl. aus einer wissenschaftlichen Bibliothek Sprache: Deutsch Gewicht in Gramm: 550.